City Hall
1 Dr. Carlton B. Goodlett
Place
San Francisco, CA 94102-
4689
City and County of San Francisco
Legislation Details
File #:
Version:
1
230688
Name:
Settlement of Lawsuit - Allergan Finance, LLC and
Allergan Limited - City to Receive $12,916,274 Over
5 Years
Status:
Type:
Ordinance
Passed
File created:
In control:
6/13/2023
Clerk of the Board
On agenda:
Final action:
6/13/2023
9/15/2023
Enactment date:
9/15/2023
192-23
Enactment #:
Title:
Ordinance authorizing settlement of the lawsuit filed by the City and County of San Francisco and the
People of the State of California against Allergan Finance, LLC (f/k/a Actavis, Inc., which, in turn, was
f/k/a Watson Pharmaceuticals, Inc.) and Allergan Limited (f/k/a Allergan plc, which, in turn, was f/k/a
Actavis plc) for $12,916,274 (the City to be paid $10,156,889 over 5 years, the City’s outside counsel
to be paid $1,585,179, and the City Attorney’s Office to be paid $1,174,206); directing the Controller to
allocate funds to the City Attorney’s Office as provided in the settlement agreement; the lawsuit was
filed on December 18, 2018, in the United States District Court for the Northern District of California,
Case No. 3:18-cv-7591-CRB-JSC; entitled The City and County of San Francisco and the People of
the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A.
Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler,
Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P.,
Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo
International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals,
Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc f/k/a Actavis Plc,
Watson Pharmaceuticals, Inc. n/k/a Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis
Pharma, Inc. f/k/a Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and
McKesson Corporation; the lawsuit involves allegations that the Allergan defendants created a public
nuisance and violated the Unfair Competition Law by falsely and misleadingly marketing opioids as
safer than they actually are and distributing increasingly large volumes of opioids in and around San
Francisco despite knowledge of the growing epidemic caused by opioid misuse, and by failing to
prevent and report suspicious opioid orders as required by state and federal law.
Sponsors:
Attachments:
1. Leg Ver1, 2. Comm Pkt 072023, 3. Board Pkt 090523, 4. Board Pkt 091223, 5. Leg Final
Action By
Date
Action
Result
Ver.
RECEIVED FROM DEPARTMENT
Clerk of the Board
5/26/2023
1
RECEIVED AND ASSIGNED
President
6/13/2023
1
RECOMMENDED
Government Audit and Oversight
Committee
7/20/2023
1
Pass
PASSED ON FIRST READING
Board of Supervisors
9/5/2023
1
Pass
FINALLY PASSED
Board of Supervisors
9/12/2023
1
Pass
APPROVED
Mayor
9/15/2023
1